Puma Biotechnology, Inc. (PBYI)
5.72
-0.10
(-1.72%)
USD |
NASDAQ |
Dec 16, 15:02
Puma Biotechnology Research and Development Expense (Annual): 54.94M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 303.25M |
| Vanda Pharmaceuticals, Inc. | 74.43M |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| Relmada Therapeutics, Inc. | 46.18M |
| Syndax Pharmaceuticals, Inc. | 241.64M |